{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T15:56:12Z","timestamp":1775836572548,"version":"3.50.1"},"reference-count":22,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T00:00:00Z","timestamp":1393891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T00:00:00Z","timestamp":1393891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1111\/jcpt.12141","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T06:32:39Z","timestamp":1393914759000},"page":"322-324","source":"Crossref","is-referenced-by-count":6,"title":["Hydralazine-induced toxic epidermal necrolysis in a patient on continuous ambulatory peritoneal dialysis"],"prefix":"10.1155","volume":"39","author":[{"given":"J. C.","family":"Chan","sequence":"first","affiliation":[{"name":"Division of Dermatology; Department of Medicine; The University of Hong Kong; Queen Mary Hospital; Hong Kong SAR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Y.","family":"Yap","sequence":"additional","affiliation":[{"name":"Division of Nephrology; Department of Medicine; The University of Hong Kong; Queen Mary Hospital; Hong Kong SAR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. K.","family":"Yeung","sequence":"additional","affiliation":[{"name":"Division of Dermatology; Department of Medicine; The University of Hong Kong; Queen Mary Hospital; Hong Kong SAR China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2014,3,4]]},"reference":[{"key":"10.1111\/jcpt.12141-BIB0001|jcpt12141-cit-0001","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1468-3083.2008.02718.x","article-title":"Alan Lyell and Lyell's syndrome","volume":"22","author":"Revuz","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/jcpt.12141-BIB0002|jcpt12141-cit-0002","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archderm.1987.01660330071012","article-title":"Toxic epidermal necrolysis: clinical findings and prognosis factors in 87 patients","volume":"123","author":"Revuz","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1111\/jcpt.12141-BIB0003|jcpt12141-cit-0003","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0895-4356(95)00004-N","article-title":"An international collaborative case-control study of severe cutaneous adverse reactions (SCAR): design and methods","volume":"45","author":"Parsells-Kelly","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/jcpt.12141-BIB0004|jcpt12141-cit-0004","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/11532540-000000000-00000","article-title":"New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited","volume":"33","author":"Paquet","year":"2010","journal-title":"Drug Saf"},{"key":"10.1111\/jcpt.12141-BIB0005|jcpt12141-cit-0005","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.clindermatol.2007.01.001","article-title":"In the pursuit of classifying severe cutaneous adverse reactions","volume":"25","author":"Wolf","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1111\/jcpt.12141-BIB0006|jcpt12141-cit-0006","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archderm.1990.01670250043005","article-title":"Toxic epidermal necrolysis (Lyell syndrome): incidence and drug etiology in France","volume":"126","author":"Roujeau","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1111\/jcpt.12141-BIB0007|jcpt12141-cit-0007","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/00128071-200001060-00003","article-title":"Drug-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"1","author":"Fritsch","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/jcpt.12141-BIB0008|jcpt12141-cit-0008","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1346-8138.1997.tb02524.x","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme","volume":"24","author":"Roujeau","year":"1997","journal-title":"J Dermatol"},{"key":"10.1111\/jcpt.12141-BIB0009|jcpt12141-cit-0009","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Investig Dermatol"},{"key":"10.1111\/jcpt.12141-BIB0010|jcpt12141-cit-0010","first-page":"190","volume-title":"Lippincott's illustrated reviews: pharmacology","author":"Mycek","year":"2000","edition":"2"},{"key":"10.1111\/jcpt.12141-BIB0011|jcpt12141-cit-0011","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00403-008-0895-5","article-title":"Drug-induced lupus erythematosus","volume":"301","author":"Vedove","year":"2008","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/jcpt.12141-BIB0012|jcpt12141-cit-0012","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0961203309106176","article-title":"Drug-induced lupus: an update on its dermatologic aspects","volume":"18","author":"Marzano","year":"2009","journal-title":"Lupus"},{"key":"10.1111\/jcpt.12141-BIB0013|jcpt12141-cit-0013","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bmj.282.6270.1121-a","article-title":"Hydralazine-induced necrotising vasculitis","volume":"282","author":"Peacock","year":"1981","journal-title":"Br Med J"},{"key":"10.1111\/jcpt.12141-BIB0014|jcpt12141-cit-0014","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/bmj.280.6212.482-a","article-title":"Cutaneous manifestations of hydrallazine toxicity","volume":"280","author":"Petty","year":"1980","journal-title":"Br Med J"},{"key":"10.1111\/jcpt.12141-BIB0015|jcpt12141-cit-0015","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/bmj.280.6212.482","article-title":"Cutaneous manifestations of hydrallazine toxicity","volume":"280","author":"Brooks","year":"1980","journal-title":"Br Med J"},{"key":"10.1111\/jcpt.12141-BIB0016|jcpt12141-cit-0016","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/bmj.280.6208.156-a","article-title":"Hydrallazine-induced cutaneous vasculitis","volume":"280","author":"Bernstein","year":"1980","journal-title":"Br Med J"},{"key":"10.1111\/jcpt.12141-BIB0017|jcpt12141-cit-0017","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-4362.1989.tb01354.x","article-title":"Bullous systemic lupus erythematosus","volume":"28","author":"Fleming","year":"1989","journal-title":"Int J Dermatol"},{"key":"10.1111\/jcpt.12141-BIB0018|jcpt12141-cit-0018","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1067\/mjd.2001.112218","article-title":"Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris","volume":"44","author":"Schaffer","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/jcpt.12141-BIB0019|jcpt12141-cit-0019","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0002-9343(98)00325-8","article-title":"Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena","volume":"105","author":"Elkayam","year":"1998","journal-title":"Am J Med"},{"key":"10.1111\/jcpt.12141-BIB0020|jcpt12141-cit-0020","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/ard.55.10.769","article-title":"Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA","volume":"55","author":"Elkayam","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/jcpt.12141-BIB0021|jcpt12141-cit-0021","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archderm.139.1.45","article-title":"Drug-induced, Ro\/SSA positive cutaneous lupus erythematosus","volume":"139","author":"Srivastava","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/jcpt.12141-BIB0022|jcpt12141-cit-0022","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaad.2008.02.021","article-title":"Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"59","author":"Lee","year":"2008","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12141","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12141","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12141\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:05:19Z","timestamp":1671818719000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,4]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12141","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3,4]]}}}